A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial (COG ACNS0331)
Diseases and Conditions Researched
Brain and Nervous System; Central Nervous System Tumor
What is the purpose of this trial?A Study Evaluating Limited Target Volume Boost Irradiation & Reduced Dose Craniospinal Radiotherapy (18.00Gy ) & Chemotherapy in Children w/Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Blind Trial
Click here for detailed participation information for this trial.
|Sponsors:||Children's Oncology Group (The); National Cancer Institute (NCI)|
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.